MEDEXUS PHARMACEUTIC.
Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases. Its primary products include IXINITY, an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B; Rasuvo and Metoject, a formulation of… Read more
Market Cap & Net Worth: MEDEXUS PHARMACEUTIC. (P731)
MEDEXUS PHARMACEUTIC. (F:P731) has a market capitalization of $64.56 Million (€62.89 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #20424 globally and #2197 in its home market, demonstrating a 2.65% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MEDEXUS PHARMACEUTIC.'s stock price €1.94 by its total outstanding shares 32420060 (32.42 Million).
MEDEXUS PHARMACEUTIC. Market Cap History: 2018 to 2026
MEDEXUS PHARMACEUTIC.'s market capitalization history from 2018 to 2026. Data shows change from $92.35 Million to $64.56 Million (-4.83% CAGR).
MEDEXUS PHARMACEUTIC. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MEDEXUS PHARMACEUTIC.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of P731 by Market Capitalization
Companies near MEDEXUS PHARMACEUTIC. in the global market cap rankings as of March 18, 2026.
Key companies related to MEDEXUS PHARMACEUTIC. by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
MEDEXUS PHARMACEUTIC. Historical Marketcap From 2018 to 2026
Between 2018 and today, MEDEXUS PHARMACEUTIC.'s market cap moved from $92.35 Million to $ 64.56 Million, with a yearly change of -4.83%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €64.56 Million | +12.14% |
| 2025 | €57.57 Million | -19.16% |
| 2024 | €71.22 Million | +38.96% |
| 2023 | €51.25 Million | +18.46% |
| 2022 | €43.26 Million | -23.08% |
| 2021 | €56.24 Million | -59.57% |
| 2020 | €139.10 Million | +64.57% |
| 2019 | €84.53 Million | -8.47% |
| 2018 | €92.35 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of MEDEXUS PHARMACEUTIC. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $64.56 Million USD |
| MoneyControl | $64.56 Million USD |
| MarketWatch | $64.56 Million USD |
| marketcap.company | $64.56 Million USD |
| Reuters | $64.56 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.